Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction
Benson Chellakkan Selvanesan(Albert Einstein College of Medicine), Geeta Upadhyay(Uniformed Services University of the Health Sciences)
Cited by 4
Related Papers
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|Journal for ImmunoTherapy of Cancer|2020|28
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4